Form D · Other Health Care

Integris AI Healthcare Group, Inc.

Washington, DC · CIK 0001001988

Offering snapshot reported Mar 17, 2026 · SEC filing

Reported sold
Yet to sell
Offering amount: $1B
Investors reported
0
Form D · investor count
Minimum accepted
$10M
Reported outside-investor minimum
First sale
Yet to occur
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 17, 2026InitialYet to sellNo comparison0SEC filing
Jan 22, 2026AmendmentYet to sellNo comparison0SEC filing
Jan 21, 2026AmendmentYet to sellNo comparison0SEC filing
Oct 24, 2025AmendmentYet to sellNo comparison0SEC filing
Oct 24, 2025AmendmentYet to sellNo comparison0SEC filing
Aug 19, 2025AmendmentYet to sellNo comparison0SEC filing
Jan 22, 2025InitialYet to sellNo comparison0SEC filing

Offering details

Securities
Equity, Debt
Exemptions
06c
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$17.5M
Form D file number
021-576732
This offering announcement seeks funding for artificial intelligence (AI) electronic health records integrated patient services and facilities.
Based upon a 1.75% finder's fee. A regressive promoter fee is also provided. Performance bonuses are also provided for.

Source: Form D, filed Mar 17, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Anthony Eladio Ramos Promoter

Issuer details

Industry: Other Health Care (See others in industry)

Address:
20 F Street, Nw Suite 700
Washington, DC, 1000520001
Phone: 646-939-2870